tiprankstipranks
Urogen Pharma (URGN)
NASDAQ:URGN
US Market
URGN
Urogen Pharma
RESEARCH TOOLSreports

Urogen Pharma (URGN) Cash flow

654 Followers

Urogen Pharma Cash Flow

URGN's free cash flow for Q4 2025 was $-38.34M. For the 2025 fiscal year, URGN's free cash flow was decreased by $-65.67M and operating cash flow was $-38.33M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -162.44M$ -96.77M$ -76.38M$ -87.56M$ -84.89M
Investing Cash Flow
$ 61.56M$ -20.61M$ -953.00K$ 1.06M$ 4.07M
Financing Cash Flow
$ 39.92M$ 194.62M$ 116.93M$ 97.13M$ 72.32M
End Cash Position
$ 112.09M$ 173.06M$ 95.82M$ 56.22M$ 45.59M
Free Cash Flow
$ -162.73M$ -97.06M$ -76.57M$ -87.81M$ -85.64M
Currency in USD

Urogen Pharma Cash Flow